-
“Astha -15” aids in the speedy recovery of COVID-19 patients
-
Dalmia Research gets AYUSH sanction to market a first-of-its-kind COVID Treatment formulation
-
DCRD developed15 herb Ayurvedic formulation is a global first in COVID treatment, puts India as a leading player in COVID pharmaceutics
-
Dalmia gets India & Ayurveda on World COVID Map
Noida [India]: In possibly, the proudest reason for India to cheer about during these pandemic times, Dalmia Healthcare Limited very soon will be announcing the launch of the polyherbal combination of 15 herbs called Astha-15 for the treatment of COVID-19 along with standard care approved as per AYUSH/ICMR guidelines. This Ayurvedic (Indian System of Medicine) polyherbal capsule has been developed with the rationale to provide a safe and effective Ayurvedic formulation for the patients suffering from COVID and shown remarkable results.
“This is a proud moment for India, our own indigenous Ayurveda and Dalmia Healthcare Limited –has developed Astha-15 for the effective treatment of respiratory disorders in COVID patients,” says Sanjay Dalmia, Chairman, Dalmia Group of Companies. Dalmia’s research arm Dalmia Centre for Research and Development (DCRD) has developed Astha-15 after extensive research and developed this polyherbal combination.
“We are happy to announce that the outcome of the Clinical Trial showed that Astha-15 has significantly reduced the cough and wheezing, improved the respiratory rate and aid in the speedy recovery of COVID-19 patients with the improvement of quality of life during the treatment cycle,” asserts Dalmia.
Aptly named Astha or faith, Astha-15 brings back the faith of the healthcare fraternity in Ayurveda. The pathbreaking medicine acts as a bronchodilator, decongestant, anti-inflammatory and lung detoxifier. It helps in eliminating the infection and regulating the allergic reactions. This has a specific action on the mucosa of the respiratory tract and the muscular walls of the lungs that act as the airways. It has an anti-inflammatory effect which reduces inflammation and congestion inside the lungs. Its continuous use reduces the damage on the lungs and the muscular walls and brings out a significant reversal in their dysfunction. All these disorders which have been found in COVID19 patients have been confirmed to be treated by Astha-15.
Dalmia Healthcare had earlier sought approval for Astha-15 by conducting a clinical trial to evaluate the efficacy and safety of polyherbal combination for the treatment of COVID-19 along with standard care approved as per AYUSH/ICMR guidelines. After two successful phases, Phase III trial was conducted on 120 subjects at multi-centric sites viz. JNUIMSRC, Jaipur, Govt. Medical College & Govt. General hospital, Srikakulam (Old RIMSGGH) and RGMC & CSMH, Thane by following the regulatory guidelines of AYUSH and the Informed Consent Declaration, Insurance Terms and Hospital Ethics Committee approvals which are registered at DCGI to perform the clinical trial. This phase III clinical trial has been registered on CTRI with reg. no. CTRI/2020/06/025590.
Astha-15 will be made available in the First Phase through prescriptions written for mild and moderate COVID patients undergoing treatment in COVID Hospitals. Dalmia Healthcare would be applying for permission/approval of Astha-15 usage in allopathic hospitals, as per the procedure in each hospital.
Dalmia’s Astha-15 will be the first Ayurvedic drug and an indigenous formulation from India in the global market addressing the respiratory disorders in COVID. Its arrival will bring in immediate faster recovery relief to lakhs of COVID patients.
About Dalmia Health Care:
Dalmia Healthcare Limited (DHL), a Dalmia Group Company, has made foray into the healthcare business in the year 2000 and offers plant-based formulations (Ayurvedic/herbal) prepared through scientific validation followed by clinical trials undertaken by its research centre, Dalmia Centre for Research and Development (DCRD).
The essence of pre-marketing efforts focuses on clinical trials compared and measured with those for various Allopathic drugs indicated for similar conditions. Extensive toxicological studies are conducted while formulating DHL products in order to ensure that our products are safe and devoid of adverse side-effects. All products of Dalmia Healthcare are manufactured and evaluated in accordance with the standards of modern medical parameters.
![New Delhi, [India], June 26 2024: Haier Appliances India, the No.1 global major appliances brand for 15 consecutive years, announced the launch of the new Kinouchi Dark Edition Air Conditioner - the perfect combination of innovative technology and premium aesthetics. Curated to provide the best in class customer experience, the new air conditioner boasts advanced technologies like Supersonic Cooling in 10 seconds, Frost Self-Clean Technology, HEXA Inverter Technology, Intelli Convertible 7-in-1, and much more. Available in 1.6 tons and 1.0 tons, it will be available across all retail channels Committed to producing innovative products for Indian consumers, Haier India has constantly evolved to meet consumer demands for inspired living. With a focus on customer-driven innovation, the brand is focused on delivering a premium experience for consumers with the new launch. Commenting on the new launch, Mr. NS Satish, President, Haier Appliances India said, “At Haier India, prioritizing the evolving needs of consumers has remained fundamental to our ethos. Over the years along with offering innovative solutions that make everyday life smarter, convenient and comfortable, we have focused on curating an ecosystem of products that cater to rising demand for aesthetically designed premium products. Committed to creating customer-inspired innovations, all of our air conditioners, including the latest Kinouchi Dark Edition, are manufactured in India and meticulously designed for the Indian market. With this the air conditioner, we're presenting consumers with a premium product with advanced features, ensuring they can combat the summer heat with both efficiency and style.” Premium aesthetics and design In recent years, there has been a noticeable shift among Indian consumers placing increased importance on the aesthetics of their homes, viewing them as reflections of their personalities. Acknowledging this evolving trend and the growing demand, Haier has introduced the Kinouchi dark edition air conditioner which is not just a cooling device. The model combines premium technology, innovation, and a chic design, bringing a renewed sense of elegance and excellence to home spaces. Supersonic cooling in 10 seconds A standout feature of the new air conditioner is its ability to deliver a 20X faster cooling experience than conventional air conditioners. Additionally, the model is engineered to provide efficient cooling even in extreme temperatures, reaching up to 60 degrees Celsius. Frost Self-Clean Technology The new Kinouchi model is crafted to provide healthy, clean air, aligning with Haier's commitment to Indian customers. The Frost Self-Clean Technology in the entire inverter air conditioner range ensures 99.9% sterilization, circulating perfectly clean air in just 15 minutes and drying time of 6 minutes. HEXA Inverter Technology Backed by Full DC Inverter technology with electronic expansion valve and dual DC compressor, the air conditioner comes with a highly robust design which provides additional powerful performance. Intelli Convertible - 7 in 1 This intelligent convertible feature allows users to reduce the cooling capacity of the air conditioners as per their need. The Intelli Pro Sensor also provides self-adjustment for efficient performance. This will help the users to choose the tonnage of the air conditioner as per their requirement, resulting in more energy savings. 20-metre-long air flow The latest model features a 'TURBO' mode, ensuring consistent and powerful cooling for Indian households. With an efficient 20-meter-long airflow, cooling swiftly reaches every corner of the room. Longevity Haier’s new air conditioner model is fortified with high ambient performance. Its special design and effective conformal coating protect the appliance components from external elements, ensuring effective performance in the long run. Additionally, it is equipped with a Hyper PCB (Printed Circuit Board) to deliver and maintain stable operations, enhancing the longevity of the air conditioners. Price and availability • Haier Kinouchi Dark Edition air conditioner will be available across India at a starting price INR 46,990 • As part of the launch offer, Haier India is providing a 5-year comprehensive warranty valued at INR 15,990, along with cashback offers of up to 10%. The offer also includes free installation and a lifetime compressor warranty.](https://metrocitynews.in/wp-content/uploads/2024/06/WhatsApp-Image-2024-06-26-at-6.10.53-PM-120x86.jpeg)
